Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pharmaceutics|February 26, 2022
Fast-Dissolving Nifedipine and Atorvastatin Calcium Electrospun Nanofibers as a Potential Buccal Delivery SystemHassa A Alshaya, Ahmed J Alfahad, Fatemah M Alsulaihem, et al.Pharmaceutics|April 30, 2021
Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold NanoparticlesHaya A Alfassam, Majed S Nassar, Manal M Almusaynid, et al.Pharmaceutics|September 23, 2022
Reply to Zandi, M.; Soltani, S. Comment on "Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. Pharmaceutics 2021, 13, 502"Haya A Alfassam, Majed S Nassar, Manal M Almusaynid, et al.Genomics|April 10, 2021
Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortalityJahad Alghamdi, Manal Alaamery, Tlili Barhoumi, et al.Clinical Genetics|April 24, 2020
ADAMTS19-associated heart valve defects: Novel genetic variants consolidating a recognizable cardiac phenotypeSalam Massadeh, Amal Alhashem, Ingrid M B H van de Laar, et al.Journal of Molecular Medicine (Berlin, Germany)|January 5, 2021
A cell-based drug delivery platform for treating central nervous system inflammationOren Levy, Veit Rothhammer, Ivan Mascanfroni, et al.Biomedical Reports|March 23, 2018
Therapeutics discovery: From bench to first in-human trialsEnsaf M Al-Hujaily, Tanvir Khatlani, Zeyad Alehaideb, et al.Medrxiv : the Preprint Server for Health Sciences|January 5, 2021
Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, et al.The Journal of Clinical Investigation|May 27, 2021
Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, et al.Plos Genetics|November 3, 2022
Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics InitiativeGuillaume Butler-Laporte, Gundula Povysil, Jack A Kosmicki, et al.Pageof 3